Pharmaceutical

Novartis and PTC Therapeutics link to develop Huntingto...

Novartis has entered a worldwide licence and partnership agreement with PTC Ther...

Faron Pharma secures UK innovation passport for blood c...

The MHRA has also granted approval to Faron Pharmaceuticals to conduct the BEXMA...

Fate Therapeutics makes Bob Valamehr president and CEO

Fate has announced the retirement of president and CEO Scott Wolchko with Bob Va...

CHMP recommends oral peanut allergy immunotherapy treat...

The EMA’s CHMP has endorsed expanding the use of Palforzia to toddlers aged one ...

PrEP therapies utter new hope in HIV preventive landsca...

The HIV vaccine space has seen dwindling research activity as drug manufacturers...

EMA launches ESMP for better management of drug shortag...

The ESMP platform enables marketing authorisation holders to report shortages an...

University of Birmingham identifies target to reduce GV...

University of Birmingham researchers have identified CD70 as a key target to red...

UK Government to launch first ever men’s health strategy

The government said that men are less likely than women to seek medical help, pa...

UK reports near eradication of meningitis C amid declin...

Meningitis C cases are down 99% since the NHS routine vaccination programme was ...

Kronos Bio announces interim CEO and workforce cuts of 83%

Kronos Bio has announced the appointment of Deborah Knobelman as president and i...

Trump agency nominations show pharma industry as divide...

Confirmation of Trump's nominations for appointments is not yet assured and the ...

Health Canada approves Novo Nordisk’s Wegovy to cut hea...

Health Canada has approved Novo Nordisk’s semaglutide injection, Wegovy, to redu...

Combatting Infectious Disease: Challenges and Opportuni...

The relationship between climate change and infectious disease is raising new qu...

CervoMed’s stock rises as FDA grants orphan drug status...

There are currently no FDA- or EMA-approved treatment options available for any ...

Wait for galactosemia therapy goes on after FDA shuns A...

The US Food and Drug Administration has declined to approve Applied Therapeutics...

Allink Biotherapeutics secures funding to advance ADC p...

Allink Biotherapeutics has completed a $42m Series A financing round to expedite...